Nasdaq · Common stock

Lycia Therapeutics (LYCA)

$28.85 −$1.15 (−3.83%)

Day’s range: $23.73–$30.91
Volume: 965,452

Monday’s close

LYCA price history

LYCA closed at $28.85 on Oct. 26, 2026. Over the past year, its daily close ranged from $28.85 on Oct. 26, 2026 to $30.00 on Oct. 23, 2026.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $28.50 to $30.00, not from zero. As of the close on Oct. 26, 2026

Data table: LYCA daily closes, the past year

LYCA daily closing prices, Oct. 23, 2026 to Oct. 26, 2026, newest first
Date	Close
Oct. 26, 2026	$28.85
Oct. 23, 2026	$30.00

Key figures

Average daily volume: 1.6MPast 3 months
Market value: $1.50B
Dividend yield: —

Monday’s close

What Wall Street says about LYCA

No Wall Street firm has published a rating or price-target change on LYCA in the past 90 days.

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

About Lycia Therapeutics, Inc. Common Stock

Lycia Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases.

Listed: Oct. 23, 2026

lyciatx.com, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about LYCA is on the site yet.